Asset Dedication LLC’s AMAG Pharmaceuticals AMAG Stock Holding History

Asset Dedication LLC’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1	Closed	–	–	811
2018 Q2	$0	Buy	+1	New	+$22	﹤0.01%	791

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Asset Dedication LLC's AMAG Position: Q3 2018 in Review

Asset Dedication LLC sold out of AMAG Pharmaceuticals (AMAG) in Q3 2018, closing a stake of 1 share.

Asset Dedication LLC first reported a position in AMAG in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 182 funds tracked by Wall St. Rank hold AMAG as of Q3 2018.

Asset Dedication LLC reported no remaining AMAG Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Asset Dedication LLC sold 1 AMAG Pharmaceuticals share in Q3 2018.
Asset Dedication LLC first reported a position in AMAG Pharmaceuticals in Q2 2018 and held it in 1 quarter.
Asset Dedication LLC's AMAG Pharmaceuticals position peaked at $0 in Q2 2018.
182 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2018.

Based on Asset Dedication LLC's 13F filing for Q3 2018, filed 26 Oct 2018.